[HTML][HTML] Results of dasatinib therapy in patients with early chronic-phase chronic myeloid leukemia
Journal of Clinical Oncology, 2010•ncbi.nlm.nih.gov
Results of Dasatinib Therapy in Patients With Early Chronic-Phase Chronic Myeloid
Leukemia - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text
Archive Search in PMC Advanced Search User Guide Journal List J Clin Oncol
PMC2815702 Other Formats PubReader PDF (220K) Actions Cite Collections Share
Permalink Copy RESOURCES Similar articles Cited by other articles Links to NCBI …
Leukemia - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text
Archive Search in PMC Advanced Search User Guide Journal List J Clin Oncol
PMC2815702 Other Formats PubReader PDF (220K) Actions Cite Collections Share
Permalink Copy RESOURCES Similar articles Cited by other articles Links to NCBI …
Abstract
Purpose
Dasatinib is effective therapy for chronic myeloid leukemia (CML) after imatinib failure. In this study, we investigate the efficacy of dasatinib as initial therapy for patients with CML in early chronic phase.
ncbi.nlm.nih.gov
